Heinz Lubenau
Keine laufenden Positionen mehr
Profil
Heinz Lubenau was the founder and had founded Vaximm AG in 2008, where he held the title of Chief Executive Officer until 2022.
He has worked as a Principal at BioGeneriX AG and Servier Laboratories Ltd.
He holds a doctorate degree from The Johannes Gutenberg University of Mainz.
Ehemalige bekannte Positionen von Heinz Lubenau
| Unternehmen | Position | Ende |
|---|---|---|
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Vorstandsvorsitzender | 01.11.2022 |
Servier Laboratories Ltd.
 Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Servier Laboratories Ltd. develops and manufactures pharmaceuticals. Its product portfolio includes Lonsurf, Oncaspar, Pixuvri, Valdoxan, and Natrilix. The company was founded in 1964 and is headquartered in Stoke Poges, the United Kingdom. | Corporate Officer/Principal | - |
BioGeneriX AG
 BioGeneriX AG Pharmaceuticals: MajorHealth Technology BioGeneriX AG develops bioengineered drugs used in the treatment of anemia, cancer, renal disease, multiple sclerosis and neutropenia. The company was founded in June 2000 and is headquartered in Mannheim, Germany. | Corporate Officer/Principal | - |
Ausbildung von Heinz Lubenau
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BioGeneriX AG
BioGeneriX AG Pharmaceuticals: MajorHealth Technology BioGeneriX AG develops bioengineered drugs used in the treatment of anemia, cancer, renal disease, multiple sclerosis and neutropenia. The company was founded in June 2000 and is headquartered in Mannheim, Germany. | Health Technology |
Servier Laboratories Ltd.
Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Servier Laboratories Ltd. develops and manufactures pharmaceuticals. Its product portfolio includes Lonsurf, Oncaspar, Pixuvri, Valdoxan, and Natrilix. The company was founded in 1964 and is headquartered in Stoke Poges, the United Kingdom. | Health Technology |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
